,   announced the opening of an office in Tokyo, Japan under the wholly owned subsidiary of CoreLab Partners Japan, K.K.

“We are pleased to announce the creation of our new subsidiary in Asia corresponding with the opening of an office in central Tokyo” said CoreLab Partners’ President and Chief Executive Officer, Dr. Mike Woehler.  “This expanded presence is a natural extension of our geographic reach and global strategy to serve our growing base of multinational biopharma companies operating in the region and will complement our operational capability which was established in Shanghai, China over a decade ago” added Woehler. 

CoreLab Partners currently has a business alliance in Japan with Suzuken Co. Ltd. which markets its cardiac safety services; this new presence is designed to further establish the global brand in the Pacific Rim and expand their full line of imaging sciences capabilities in Southeast Asia.  “CoreLabs has been present in the region since 1999 and has conducted hundreds of drug development studies in both cardiac safety and imaging for a variety of sponsor partners.  The addition of a local Regional Director and Business Development professional will allow CoreLab Partners to better service our client base by nurturing current relationships and opening up new markets for our full line of cardiac safety and imaging services” said Kevin Duffy, Vice President, Global Business Development.